Julius Ntshangase

发表

Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial.

S. Delany-Moretlwe, L. Myer, H. Rees, 2018, The Lancet. Infectious diseases.